Janssen Biotech, Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Biologic Drugs for Janssen Biotech, Inc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 1994-12-22 | See Plans and Pricing | |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 1998-08-24 | See Plans and Pricing | |
Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | See Plans and Pricing | |
Janssen Biotech, Inc. | SIMPONI | golimumab | Injection | 125289 | 2009-04-24 | See Plans and Pricing | |
Janssen Biotech, Inc. | SIMPONI ARIA | golimumab | Injection | 125433 | 2013-07-18 | See Plans and Pricing | |
Janssen Biotech, Inc. | CARVYKTI | ciltacabtagene autoleucel | For Injection | 125746 | 2022-02-28 | See Plans and Pricing | |
Janssen Biotech, Inc. | DARZALEX | daratumumab | Injection | 761036 | 2015-11-16 | See Plans and Pricing | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
This search can help find similar names.